Subscribe to Drug Discovery & Development News

The Lead

Novartis, Aduro: Up-to-$750M Cancer Immunotherapy Collaboration

March 30, 2015 | by Stephanie Guzowski, Editor | Comments

Novartis is planning to boost its cancer immunotherapy pipeline with a collaboration with California-based Aduro Biotech worth up to $750 million. Read more...

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Medieval Remedy Found to be Highly Effective Against MRSA

March 31, 2015 1:37 pm | by Stephanie Guzowski, Editor | Comments

British researchers recently found that a thousand-year-old Anglo-Saxon treatment for eye infections works as an antibiotic against MRSA. Read more...


Blood-Based Biomarkers Could Enable Accurate TB Tests for Diagnosis

March 31, 2015 11:48 am | by Emory University | Comments

Researchers have identified blood-based biomarkers in patients with active tuberculosis (ATB) that could lead to new blood-based diagnostics and tools for monitoring treatment response and cure. Read more...


Quintiles, Quest to Join to Provide Global Clinical Trials Lab Services

March 31, 2015 11:38 am | Comments

Quintiles and Quest Diagnostics announced a definitive agreement to form a global clinical trials laboratory services business. Read more...


Publication Bias, 'Spin,' Raise Questions About Anxiety Drugs

March 31, 2015 11:32 am | by Oregon State University | Comments

A new analysis reported in JAMA Psychiatry raises serious questions about the increasingly common use of second-generation antidepressant drugs to treat anxiety disorders. Read more...


Arizona Governor Signs Abortion Drug Notification Mandate

March 31, 2015 11:22 am | by Bob Christie and Ryan Van Velzer, Associate Press | Comments

Gov. Doug Ducey signed a bill Monday that requires abortion providers in Arizona to tell women they can reverse the effects of a drug-induced abortion and also bars women from buying any health care plan through the federal marketplace that includes abortion coverage. Read more...


Merck Serono, Intrexon Agree to Develop, Commercialize CAR-T Therapy

March 31, 2015 10:21 am | Comments

Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. Read more...


The Genomic Portrait of a Nation

March 29, 2015 4:01 pm | Comments

The studies present the most detailed portrait of a population yet assembled using the latest technology for reading DNA. Read more...


Novo to Launch Novoeight in the U.S. for People With Hemophilia A

March 29, 2015 3:38 pm | Comments

The US Food and Drug Administration (FDA) approved Novoeight for use in adults and children with hemophilia A for the control and prevention of bleeding, perioperative management, and routine prophylaxis. Read more...


Integrative Approaches Key to Understanding Cancer and Developing Therapies

March 29, 2015 3:16 pm | by Moffitt Cancer Center | Comments

Researchers are using integrative approaches to study cancer by combining mathematical and computational modeling with experimental and clinical data. Read more...


Colleges Getting Out of Health Insurance Business

March 29, 2015 3:05 pm | by Donna Gordon Blankinship, Associated Prss | Comments

The federal health care overhaul is leading some colleges and universities to get out of the health insurance business. Read more...


Cells Rebound after Treatment for Most Children with HIV, Low Immune Cell Count

March 27, 2015 2:13 pm | by Enrique Rivero, UCLA | Comments

Most children with HIV who have low levels of a key immune cell eventually recover levels of this cell after they begin treatment. Read more...

MRI based on Sugar Molecule Can Tell Cancerous from Noncancerous Cells

March 27, 2015 2:06 pm | by Johns Hopkins University | Comments

Preliminary study in lab-grown cells raises possibility of cancer diagnosis without biopsies. Read more...


Nanoparticle Therapy Promotes Wound Healing

March 27, 2015 2:00 pm | by Yeshiva University | Comments

An experimental therapy can cut in half the time it takes to heal wounds compared to no treatment at all. Read more...


Answers to Common Questions about HIV, Needles, and Drug Use

March 27, 2015 1:47 pm | by Carla K. Johnson, AP Medical Writer | Comments

Indiana Gov. Mike Pence has authorized a short-term needle-exchange program and other steps to help contain the spread of HIV among intravenous drug users in one county. Read more...


Eisai Receives Japanese Approval for Anticancer Agent

March 27, 2015 1:40 pm | Comments

Eisai announced that it has received manufacturing and marketing authorization in Japan for its in-house developed novel anticancer agent. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.